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pening of the permeability transition pore (PTP) has
been implicated as an important mitochondrial
event that occurs during apoptosis. We examined the
role of the PTP in the well-characterized cell death of rat
sympathetic neurons deprived of nerve growth factor (NGF) in
vitro. Removal of NGF causes these neurons to undergo either
a classic apoptotic cell death or, when treated with a broad-
spectrum caspase inhibitor such as boc-aspartyl(OMe)-
ﬂuoromethylketone (BAF), a delayed, nonapoptotic cell
O
 
death. The PTP inhibitor, cyclosporin A (CsA), blocked
commitment-to-die in the presence of BAF, as deﬁned by the
ability of NGF readdition to rescue cells, but had little effect
on commitment-to-die in the absence of BAF. CsA did not
have trophic effects on BAF-saved cells, but did block the
decrease in mitochondrial membrane potential. These data
suggest that PTP opening is a critical event in caspase-
independent, nonapoptotic (but not caspase-dependent,
apoptotic) death of NGF-deprived rat sympathetic neurons.
 
Introduction
 
Programmed cell death (PCD)* is an orderly, cell-autonomous
process by which excess cells are eliminated during devel-
opment. Cells undergoing PCD display certain morpho-
logical features, such as cytoplasmic shrinkage, plasma
membrane blebbing, chromatin condensation, and nuclear
fragmentation. These features describe a form of cell death
termed apoptosis (Kerr et al., 1972). Although the occur-
rence of PCD during development has long been known, its
apoptotic features have been recognized more recently in
pathological conditions of many tissues.
Apoptosis is executed by caspases, a family of cysteine
proteases which are synthesized as relatively inactive zymogens,
or procaspases (for review see Cryns and Yuan, 1998). In
mammalian cells undergoing apoptosis, caspase activation is
regulated principally by two mechanisms. In the intrinsic
pathway, which is triggered by apoptotic stimuli such as
trophic factor withdrawal and DNA damage, the activation
of caspases is regulated by the convergence of signals at the
mitochondrion, such as those mediated by the BCL-2 fam-
ily of proteins. These signals lead to the release of cytochrome
c from the intermembrane space of the mitochondria to the cy-
tosol, where it interacts with the apoptosome, a large complex
containing procaspase-9, APAF-1, and dATP, activating cas-
pase-9 (Li et al., 1997). In contrast, in the extrinsic pathway,
cell surface receptors, such as TNFR1 and Fas/CD95/
APO-1, can directly activate caspase-8 through a signaling
complex including the cytoplasmic tail of these receptors
and procaspase-8 (Muzio et al., 1996). The separation be-
tween these pathways is not absolute, as cleavage of the
proapoptotic BCL-2 family member, BID, by caspase-8
can lead to mitochondrial release of cytochrome c (Li et al.,
1998; Luo et al., 1998).
The importance of the mitochondrion in apoptosis has
lead to the examination of mitochondrial physiology for
mechanistic roles in cell death. One such event is the open-
ing of the permeability transition pore (PTP), a transient
channel 2–3 nm in diameter connecting the cytosol and the
mitochondrial matrix (for review see Crompton, 1999). The
PTP is composed of at least three proteins in different com-
partments of the mitochondria: the voltage-dependent anion
channel in the outer mitochondrial membrane (OMM), the
adenine nucleotide translocase in the inner mitochondrial
membrane, and cyclophilin D in the mitochondrial matrix.
The PTP forms transiently under normal physiologic condi-
tions, but under certain conditions, such as high calcium or
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low ATP levels, prolonged opening of the PTP leads to mi-
tochondrial matrix swelling and rupture of the OMM. Two
predicted consequences of this gross disruption of the
OMM are the release of cytochrome c from the intermem-
brane space and the loss of the mitochondrial membrane po-
tential (
 
  
 
m
 
), leading to speculation that PTP opening may
be the mechanism by which these events occur during apop-
tosis. Consistent with this, loss of 
 
  
 
m
 
 and cytochrome c
release occur simultaneously in several models of cell death
(Bradham et al., 1998; Heiskanen et al., 1999). Further-
more, pharmacologic inhibition of PTP opening by cy-
closporin A (CsA) or bongkrekic acid inhibits cell death in a
number of model systems (for review see Vieira et al., 2000).
However, in some experimental paradigms, 
 
  
 
m
 
 is main-
tained, or even elevated, during and after cytochrome c re-
lease, arguing that the mechanism of cytochrome c release
does not involve PTP opening (Vander Heiden et al., 1997;
Bossy-Wetzel et al., 1998; Goldstein et al., 2000).
In this study, we examined the role of the PTP in NGF
deprivation–induced death of sympathetic neurons from the
superior cervical ganglion in vitro, a model of naturally oc-
curring cell death in the developing nervous system. This cell
death shows many morphological characteristics of apoptosis
and requires protein synthesis (Martin et al., 1988), the
proapoptotic Bcl-2 family member BAX (Deckwerth et al.,
1996), and caspase activity (Deshmukh et al., 1996; Troy et
al., 1996). Many of the early events in this cell death pathway
are reversible, such that sympathetic neurons that have been
deprived of NGF for a short time can fully recover after
trophic factor readdition (Deckwerth and Johnson, 1993;
Edwards and Tolkovsky, 1994). In sympathetic neurons, the
time course with which cells can no longer be rescued by
NGF, or become committed-to-die, is virtually identical to
the time course of cytochrome c release and rapidly ensuing
caspase activation (Putcha et al., 1999). If caspase activity is
inhibited by the broad-spectrum caspase inhibitor, boc-
aspartyl(OMe)-fluoromethylketone (BAF), NGF-deprived
sympathetic neurons can be rescued by NGF after they have
released cytochrome c (Martinou et al., 1999). This protec-
tion is finite in duration, because BAF-saved cells eventually
die by a nonapoptotic, caspase-independent mechanism
(Deshmukh et al., 2000). This stands in contrast to the pro-
tection afforded by BAX deletion, which permanently pre-
vents neuronal death after NGF deprivation (Deckwerth et
al., 1996). Before caspase inhibitor–saved cells die, they lose
the ability to be rescued by NGF and become committed-to-
die. The commitment-to-die in the presence of a caspase in-
hibitor is termed Commitment 2, to distinguish it from the
commitment-to-die in the absence of a caspase inhibitor,
termed Commitment 1. The mitochondrial hit or the pertur-
bation of the mitochondria that results from BAX transloca-
tion and cytochrome c release, is critical to Commitment 2,
as BAX deletion prevents both these mitochondrial changes
and the onset of Commitment 2.
Here, we report that CsA inhibited Commitment 2, but
not Commitment 1, in rat sympathetic neurons, suggesting
that PTP opening was a critical event in the commitment-
to-die in the presence, but not the absence of, a caspase in-
hibitor. CsA acted downstream of cytochrome c release to
block the loss of mitochondrial membrane potential, argu-
ing that opening of the PTP was responsible for the loss of
 
  
 
m
 
 associated with Commitment 2. Remarkably, CsA had
no effect on Commitment 2 in mouse sympathetic neurons,
suggesting important species differences exist in this cell
death pathway. These results have important implications
regarding the use of caspase inhibitors as neuroprotectants.
 
Results
 
CsA delays commitment-to-die in rat sympathetic 
neurons in the presence of a caspase inhibitor
 
To investigate the role of PTP opening in cell death in the
presence of a caspase inhibitor, we examined the effects of
the PTP inhibitor, CsA, on Commitment 2. Rat sympa-
thetic neurons were deprived of NGF in the presence of the
broad-spectrum caspase inhibitor BAF with or without 10
 
 
 
M CsA for various times, after which rescue by NGF read-
dition was attempted. After 7 d of NGF rescue, the number
of viable cells was counted to determine the percentage of
cells that had not committed-to-die. Fig. 1 A shows exam-
ples of cells after 10 d of treatment. NGF-deprived cells
treated with BAF or BAF and CsA appeared atrophic but
maintained phase-bright soma and intact neurites. After 7 d
of rescue with NGF, cells that were not committed-to-die in
both treatment groups displayed an increase in cell size in re-
sponse to 7 d of NGF rescue (Fig. 1 A).
As shown in Fig. 1 B, the proportion of NGF-deprived,
BAF-saved cells that was rescued by NGF decreased with in-
creasing time of NGF deprivation. About 60% of cells
treated with BAF alone became committed-to-die within the
first 12 d of NGF deprivation. After this, the rate of com-
mitment-to-die decreased greatly, such that 
 
 
 
25% of BAF-
saved cells were rescued by NGF readdition after 35 d of
NGF deprivation. Concurrent treatment with 10 
 
 
 
M CsA
dramatically inhibited the onset of Commitment 2, increas-
ing the number of cells that was able to respond to readdi-
tion of NGF at all time points between 4 and 35 d of NGF
deprivation. Most notably, CsA nearly completely blocked
the initial, rapid onset of Commitment 2, such that after 10
d of NGF deprivation, 
 
 
 
90% of cells treated with BAF and
CsA were rescued, versus 
 
 
 
40% of cells treated with BAF
alone. Even after 35 d of NGF deprivation in the presence of
BAF and CsA, 
 
 
 
60% of neurons were rescued by NGF re-
addition. Thus, CsA conferred robust and sustained inhibi-
tion of Commitment 2 in rat sympathetic neurons, suggest-
ing that PTP opening is a critical event in Commitment 2.
 
PTP opening is not required for commitment-to-die 
in rat sympathetic neurons in the absence 
of a caspase inhibitor
 
All known NGF deprivation–induced events that occur
proximal to caspase activation are common to the pathways
of both Commitment 1 and Commitment 2. Therefore,
CsA could delay Commitment 2 indirectly by inhibiting sig-
nal transduction events upstream of cytochrome c release,
such as activation of the JNK pathway, that are common to
both Commitment 1 and Commitment 2. Alternatively,
CsA could directly affect Commitment 2 by inhibiting
events downstream of cytochrome c release that are specific 
 
 
CsA inhibits Commitment 2 in rat sympathetic neurons |
 
 Chang and Johnson 773
 
to Commitment 2. To determine whether CsA affected
proximal events in the cell death pathway, the effect of CsA
on Commitment 1 was examined. Cells were deprived of
NGF in the presence or absence of 10 
 
 
 
M CsA for various
times before being rescued with NGF. In the absence of
CsA, 
 
 
 
75% of neurons became committed-to-die by 24 h
of NGF deprivation, with nearly all cells becoming commit-
ted-to-die after 4 d (Fig. 2 A). CsA had little effect on Com-
mitment 1, although the proportion of CsA-treated cells
that could be rescued by NGF was slightly increased. Al-
though this effect was seen in multiple independent experi-
ments, the magnitude of the inhibition was small and tran-
sient. Similarly, CsA slightly delayed, but did not prevent,
the death of NGF-deprived cells, as determined by loss of
toluidine blue staining (unpublished data). Thus, whereas
CsA greatly inhibited Commitment 2, it had little effect on
Commitment 1.
Next, we examined by immunocytochemistry whether
CsA affects the loss of mitochondrial cytochrome c. NGF-
maintained neurons exhibited a bright, punctate staining
pattern (see Fig. 5 A), indicative of mitochondrial localiza-
tion of cytochrome c, which is lost when cytochrome c is re-
leased into the cytosol and subsequently degraded (Desh-
mukh and Johnson, 1998; Neame et al., 1998). When
deprived of NGF, 
 
 
 
50% of cells retained mitochondrial cy-
tochrome c after 24 h of NGF deprivation, with this propor-
tion decreasing to 
 
 
 
10% after 72 h. Exposure to 10 
 
 
 
M
CsA had no effect on cytochrome c status after 24 h, and
only slightly increased the number of cells with intact cy-
tochrome c after 72 h of NGF deprivation. Similar to the
effect of CsA on Commitment 1, its effect on the loss of
mitochondrial cytochrome c was of small magnitude and
transient, as all NGF-deprived cells treated with BAF and
CsA eventually lost cytochrome c (see Fig. 5 A). Thus, CsA
had only a minor effect on cytochrome c release as deter-
mined by both NGF rescue and immunocytochemistry.
To further exclude an action of CsA on events proximal to
the mitochondria, we examined the effect of CsA on the rate
of protein synthesis. Protein synthesis rates, as determined by
measuring the incorporation of radiolabeled methionine and
cysteine, decrease upon NGF deprivation (Deckwerth and
Johnson, 1993) but are preserved by neuroprotectants that act
proximal to the mitochondria, such as depolarizing levels of
potassium, cyclic AMP analogues, and inhibition of the JNK
pathway (Rydel and Greene, 1988; Harris et al., 2002). As
shown in Fig. 2 C, CsA had no effect on this decrease in pro-
tein synthesis. Thus, CsA did not block early metabolic
changes caused by NGF deprivation, further demonstrating
that CsA does not inhibit Commitment 2 by acting proximal
to the mitochondrial events of the cell death pathway. Nota-
bly, CsA itself did not inhibit protein synthesis, as treatment
with 10 
 
 
 
M CsA for 24 h did not significantly decrease meta-
bolic labeling of NGF-maintained cells. Because significant
inhibition of protein synthesis is sufficient to block Commit-
ment 1 and cytochrome c release, this finding was consistent
with the inability of CsA to block these events (Fig. 2, A and
B). Thus, these findings show that CsA does not act upstream
of cytochrome c release and that CsA inhibits caspase-inde-
pendent, but not caspase-dependent cell death.
To further examine the effect of CsA on the trophic status
of the cells, the effect of CsA on protein synthesis rates of cells
deprived of NGF in the presence of BAF for 10 d were exam-
ined. As seen in Fig. 2 D, CsA had no effect on the rate of
protein synthesis of cells deprived of NGF in the presence of
BAF for 10 d. A similar lack of effect was observed using so-
mal diameter (Fig. 1 A; unpublished data) or MTT reduction
(unpublished data) as measures of the trophic status of NGF-
deprived, BAF-saved cells. Thus, CsA had no effect on the
metabolic status of NGF-deprived, BAF-saved cells, further
arguing that inhibition of upstream signal transduction events
does not underlie the effect of CsA on Commitment 2.
 
Effect on Commitment 2 is not mediated by inhibition 
of calcineurin
 
CsA blocks PTP opening by binding to the mitochondrial
matrix protein cyclophilin D (Halestrap et al., 1997). CsA
also exerts immunosuppressive effects by inhibiting cal-
cineurin/nuclear factor of activated T-cells (NFAT), JNK,
and p38 pathways. Another immunosuppressant, FK-506,
also inhibits these signal transduction pathways, but does not
affect PTP opening (Matsuda et al., 2000). Therefore, we ex-
amined whether FK-506 affected Commitment 2. Cells
treated with CsA showed a dose-dependent delay in Commit-
ment 2, with the maximum effect reached at 10 
 
 
 
M (Fig. 3).
Figure 1. CsA inhibits commitment-
to-die in the presence of a caspase 
inhibitor. Sympathetic neurons were 
deprived of NGF in the presence of 
BAF or BAF plus 10  M CsA for various 
periods before being rescued with 
NGF. (A) Phase-contrast micrographs 
of cells at the time of treatment (5 d
in vitro), after 10 d of treatment (15 d 
in vitro), and 7 d after NGF rescue
(22 d in vitro) are shown. Bar, 40  m. 
(B) The proportion of BAF-saved cells 
that were rescued by NGF is plotted
as the percentage of cells rescued (left
ordinate), or the percentage committed-
to-die (right ordinate, calculated as 
100% minus the percentage of cells rescued), versus length of NGF deprivation. Differences between BAF versus BAF plus CsA at all 
time points except 0 and 2 d were statistically significant (P   0.05 by t test). The data represent mean   SD of one experiment (n   4) 
that was representative of three incomplete but overlapping independent time-course experiments. 
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At this dose, 90% of cells could be rescued by NGF after 10 d
of NGF deprivation, versus 
 
 
 
40% in BAF alone, consistent
with the data shown in Fig. 1 B. In contrast, at doses ranging
from 0.03 to 3 
 
 
 
M, FK-506 had no effect on the percentage
of cells that had committed-to-die after 10 d of NGF depriva-
 
tion. 3 
 
 
 
M FK-506 was not toxic to NGF-maintained neu-
rons (Fig. 3). Because the IC
 
50
 
 for T-cell activation by FK-506
in intact cells is 
 
 
 
10–100-fold less than that of CsA (Kino et
al., 1987), these doses of FK-506 should be sufficient to in-
hibit these signaling pathways as effectively as doses of CsA
that alter Commitment 2. This is consistent with the lack of
effect of CsA on early events of the cell death pathway (Fig.
2), which are blocked by inhibition of the JNK pathway (Har-
ris et al., 2002). These findings argue that the effect of CsA on
Commitment 2 is not due to inhibition of calcineurin/NFAT,
JNK, or p38 pathways.
 
CsA blocks NGF deprivation–induced decrease in 
 
  
 
m
 
The loss of 
 
  
 
m
 
, as measured by the 
 
  
 
m
 
-sensitive dye, Mi-
totracker Orange CM-H
 
2
 
TMRos, is a nearly perfect predic-
tive marker for the onset of Commitment 2 in mouse sym-
pathetic neurons (Deshmukh et al., 2000). To investigate
the effect of CsA on 
 
  
 
m
 
 in rat sympathetic neurons, cells
were deprived of NGF in the presence of BAF or BAF plus
10 
 
 
 
M CsA for 10 d. The status of cytochrome c and 
 
  
 
m
 
in individual cells was determined by labeling cells with Mi-
totracker Orange, followed by cytochrome c immunocy-
tochemistry. As seen in Fig. 4 A, NGF-maintained rat sym-
pathetic neurons had intact cytochrome c staining and
displayed bright Mitotracker staining. After 10 d of NGF
deprivation, BAF-treated neurons lacked both cytochrome c
staining and distinct Mitotracker staining. Rat sympathetic
neurons deprived of NGF in the presence of BAF and CsA
lacked cytochrome c staining but maintained distinct Mi-
totracker staining. This finding argues that CsA blocks NGF
deprivation– induced decrease in 
 
  
 
m
 
.
To verify this finding by another method, sympathetic
neurons were stained with 5,5
 
 
 
,6,6
 
 
 
-tetrachloro-1,1
 
 
 
,3,3
 
 
 
-
tetracetylbenzimidazolylcarbocyanine iodide (JC-1), a 
 
  
 
m
 
-
sensitive dye that aggregates and changes spectral properties
within polarized mitochondria. The intensity of JC-1 fluo-
rescence in cells deprived of NGF in the presence of BAF for
Figure 2. CsA does not affect proximal events in the cell death 
pathway. Rat sympathetic neurons were deprived of NGF in the 
presence or absence of 10  M CsA. Cells were either rescued with 
NGF readdition (A) or processed for cytochrome c immunocy-
tochemistry (B) after various times of NGF deprivation, as denoted 
on the x-axis of each graph. (A) Numbers of viable cells that 
remained after 7 d of trophic factor readdition and are plotted as a 
time course of commitment-to-die in the absence of a caspase 
inhibitor, or Commitment 1. The asterisks (*) at 1, 2, and 3 d denote 
statistical significance (P   0.05). (B) Proportions of cells with intact 
mitochondrial cytochrome c after 1 and 3 d of NGF deprivation as 
determined by cytochrome c immunocytochemistry. (C) CsA does 
not affect the early NGF deprivation–induced drop in protein 
synthesis in NGF-deprived cells in the absence of or presence 
of 10  M CsA. CsA did not inhibit protein synthesis in the presence 
of NGF (P   0.6 vs. NGF alone) after 24 h of exposure. (D) CsA had 
no effect on the rate of protein synthesis in the presence of BAF after 
10 d of NGF deprivation. Data in each panel represent mean   SEM 
of three experiments performed in quadruplicate.
Figure 3. CsA, but not FK-506, inhibits Commitment 2 in a dose-
dependent fashion. Cells were deprived of NGF in the presence of BAF 
alone or with different concentrations of CsA (0.3–30  M) or FK-506 
(0.03–3  M) for 10 d and then rescued with NGF for 7 d. CsA con-
ferred a dose-dependent effect on Commitment 2, whereas FK-506 had 
no effect on Commitment 2. Data are mean   SD (n   4) of one 
experiment that was representative of two independent experiments. 
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10 d was greatly diminished compared to NGF-maintained
cultures (Fig. 4 B). In contrast, JC-1 staining was largely
maintained in NGF-deprived cells treated with BAF and
CsA, verifying that CsA blocks the decrease in 
 
  
 
m
 
. A 10-
min pretreatment with the uncoupling agent, FCCP, com-
pletely abolished visible JC-1 aggregate staining, verifying
the 
 
  
 
m
 
-dependence of this signal.
Because the ratio of JC-1 aggregate to monomeric staining
is independent of cell number or mitochondrial density, it
can be used as a quantitative measure of 
 
  
 
m
 
. The JC-1 ra-
tio of NGF-deprived, BAF-saved neurons was 
 
 
 
40% of that
of NGF-maintained neurons when quantified with a fluo-
rescent plate reader (Fig. 4 C). The combination of BAF and
CsA increased the intensity of fluorescence to 81% of con-
trol. The dependence of the JC-1 ratio on 
 
  
 
m
 
 was verified
by exposing all treatment groups to FCCP, which decreased
the signal to 3% or less of control. Thus, mitochondria in
rat sympathetic neurons deprived of NGF in the presence of
BAF were partially depolarized after 10 d of NGF depriva-
tion. CsA significantly attenuated this NGF deprivation–
induced decrease in 
 
  
 
m
 
 in BAF-saved neurons without af-
fecting the status of cytochrome c within the cell. Because
we do not know the linearity of this assay, these results may
not be rigorously quantitative. However, taken together,
these data suggest that PTP opening is responsible for NGF
deprivation–induced loss of 
 
  
 
m
 
, and that inhibition of
PTP opening accounts for the ability of CsA to block the
onset of Commitment 2.
 
CsA is required during a distinct critical period after 
NGF deprivation
 
A striking feature of the time course of Commitment 2 in
rat sympathetic neurons is that nearly all cells that commit-
to-die over 35 d of NGF deprivation reach the Commit-
ment 2 checkpoint within the first 12 d (Fig. 1 B). One
possible explanation is that the trigger for CsA-inhibitable
commitment-to-die is not sustained throughout the entire
period of NGF deprivation, such that the 30% of cells that
survive the first 12 d of NGF deprivation never undergo
Commitment 2 because a drive for PTP opening no longer
exists. To determine whether PTP opening is a transient or
sustained event, we sought to identify the period after
NGF deprivation during which CsA exposure was required
to inhibit Commitment 2. We reasoned that if PTP open-
ing were caused by a transient event or process, then after
some critical period the continued presence of CsA would
not be necessary to inhibit Commitment 2. Alternatively,
if the driving force for PTP opening were a sustained
event, continued exposure to CsA would be necessary to
prevent Commitment 2.
To determine whether the continued presence of CsA
was necessary for its effects on Commitment 2, CsA was
 
BAF or BAF plus CsA appeared atrophic but otherwise normal when 
compared with NGF-maintained cells. (B) Similar results were 
found when monitoring the aggregated form of JC-1 as an indicator 
of 
 
  
 
m
 
. JC-1 staining was absent in NGF-maintained cells pretreated 
with 10 
 
 
 
M FCCP. Quantification of the staining intensity is shown 
in C. Data shown represent mean 
 
 
 
 SEM of three independent 
experiments. Differences between all groups in the absence of 
FCCP are statistically significant (
 
P
 
   
 
0.01). Bars, 50 
 
 
 
m.
 
Figure 4.
 
CsA inhibits NGF deprivation-induced decrease of 
 
  
 
m
 
. 
 
  
 
m
 
 in rat sympathetic neurons deprived of NGF for 10 d in the 
presence of BAF or BAF plus CsA was determined by using 
Mitotracker Orange (A) or JC-1 (B, C). (A) Cells maintained in NGF 
had mitochondrial cytochrome c immunostaining and were 
Mitotracker positive. NGF-deprived, BAF-saved cells lacked cyto-
chrome c staining and Mitotracker staining. In contrast, NGF-deprived 
cells treated with BAF plus CsA lacked cytochrome c staining but 
stained with Mitotracker. Nuclei of NGF-deprived cells treated with  
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removed from cultures deprived of NGF in the presence
of BAF and CsA at different times over a 10-d interval, af-
ter which all cells were rescued with NGF for 7 d (schema-
tized in Fig. 5 A). The number of cells that could be res-
cued with NGF at the end of the 10-d period increased
with increasing length of exposure to CsA (Fig. 5 A).
When compared with cultures treated with CsA for the
entire 10-d period, removal of CsA after 0, 2, or 4 d of
NGF deprivation decreased the proportion of cells that
were rescued by NGF. In contrast, removal of CsA after 6
or 8 d did not decrease the number of cells that were res-
cued, arguing that exposure to CsA after 6 d of NGF dep-
rivation was not necessary for maximal inhibition of Com-
mitment 2. These data argue that this CsA-sensitive event
does not contribute to Commitment 2 after the first six d
of NGF deprivation.
To determine whether delayed administration of CsA
could inhibit Commitment 2, CsA was added to NGF-
deprived, BAF-saved neurons at 2-d intervals over a 10-d
period, after which all cells were rescued with NGF (Fig.
5 B). When added at d 0, 2, or 4, CsA increased the pro-
portion of cells rescued by NGF over cultures treated
with BAF alone. However, addition of CsA after 6 d of
NGF deprivation did not increase the number of rescued
cells, suggesting that the critical period for CsA-sensitive
commitment event is complete after 6 d of NGF depri-
vation. To quantify the effects of delayed administra-
tion, the percent-maximum effect was calculated. Because
BAF-saved cells become committed-to-die over this pe-
riod, the maximum number of cells that can be saved by
any intervention, including NGF readdition, decreases
with time. This value, set as 100% effect, represents the
time course of Commitment 2 (Fig. 1 B). This value de-
creased to close to zero when CsA was added after 6 d of
NGF deprivation. Thus, CsA can modulate Commit-
ment 2 if present during the first 6 d of NGF depriva-
tion. These findings are consistent with the conclusion
from the time course of removal of CsA (Fig. 5 A) that
PTP opening must be inhibited during the first 6 d of
NGF deprivation to alter Commitment 2 in rat sympa-
thetic neurons. Taken together, these findings argue that
the drive for PTP opening is not sustained throughout
 
Figure 5.
 
CsA is required for distinct period during NGF-deprivation 
to affect Commitment 2.
 
 The effect of early removal of A or delayed 
addition of B CsA to NGF-deprived, BAF-treated cells on Commitment 
2 was determined. (A) Rat sympathetic neurons were deprived of 
NGF in the presence of BAF plus 10 
 
 
 
M CsA. As shown in the 
schematic, CsA was removed from cultures at various times after 
NGF deprivation, maintained in BAF for the duration of the 10 d, 
and then rescued with NGF. The proportion of cells that were 
rescued by NGF after this period of NGF deprivation is plotted 
as a function of the length of time cultures were exposed to CsA. 
The lower reference line (gray line) represents the percentage of 
cells treated with BAF alone that were rescued after 10 d of NGF 
deprivation, designated as zero percent effect. The upper reference 
line (dotted line) represents the maximal effect of BAF plus CsA for 
 
10 d, or 100 percent effect. Removal of CsA after 6 or 8 d still 
provided maximal inhibition of Commitment 2. Asterisks (*) indicate 
that the proportion of cells rescued in a treatment group was statisti-
cally different from the maximal effect. (B) To determine the effect 
of delayed administration of CsA, it was added to NGF-deprived, 
BAF-treated cultures at various times, as schematized. The greater 
the delay before CsA addition, the closer the proportion of cells that 
could be rescued after 10 d of NGF-deprivation (solid bars) was to 
treatment with BAF alone (gray line). The number of cells treated 
with BAF alone that could be rescued (gray line) represents the 
minimum effect (0 percent effect). The proportion of cells that 
became committed-to-die after 10 d of NGF deprivation is statistically 
different (
 
 
 
) than the minimum effect only when CsA was added after 
0, 2, or 4 d of NGF deprivation. Note that the maximum possible 
saving effect of CsA addition (empty bars) decreased during the course 
of the experiment because NGF-deprived, BAF-saved cells became 
committed-to-die. 
 
P
 
 values from Student’s unpaired 
 
t
 
 tests are shown. 
Data are mean 
 
 
 
 SD of one experiment, performed in quadruplicate, 
that was representative of two independent experiments. 
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the entire duration of NGF deprivation, but rather occurs
during a distinct critical period.
 
CsA does not delay Commitment 2 in mouse 
sympathetic neurons
 
Although the time courses of Commitment 1 are very similar
in rat and mouse sympathetic neurons, the time courses of
Commitment 2 are very different. To illustrate this difference,
time courses of Commitment 1 and Commitment 2 of sympa-
 
thetic neurons from ICR mice (Deshmukh et al., 2000) and
Sprague Dawley rat (Figs. 1 B and 2 A) were plotted on a single
graph (Fig. 6 A). About 50% of mouse sympathetic neurons
reached Commitment 2 after 60 h of NGF deprivation, versus
8 d in rat sympathetic neurons. By 5 d of NGF deprivation in
the presence of BAF, all mouse neurons are committed-to-die,
whereas nearly 30% of rat neurons can still be rescued after 35 d.
To determine whether CsA had the same effect on Commit-
ment 2 in these two species, sympathetic neurons from mice
were deprived of NGF in the presence of BAF or BAF plus
CsA for 72 h before rescue with NGF (Fig. 6 B). Surprisingly,
CsA at doses up to 10 
 
 
 
M had no effect on the proportion of
cells that were rescued by NGF. Pretreatment of cells with CsA
for 2 h did not increase its effect on Commitment 2 (unpub-
lished data). As seen with rat neurons, 10 
 
 
 
M CsA was not
toxic to NGF-maintained neurons, whereas both NGF-main-
tained and NGF-deprived, BAF-saved mouse neurons treated
died in the presence of 30 
 
 
 
M CsA (Fig. 3; unpublished data).
A similar lack of effect on Commitment 2 was found in sym-
pathetic neurons from different strains of mice, including
C57BL/6J (Fig. 6 B), Swiss-Webster, and BALB/C (unpub-
lished data). These data demonstrate that Commitment 2 in
mouse and rat sympathetic neurons had striking phenomeno-
logical and mechanistic differences.
 
Discussion
 
In this study, we examined the role of PTP opening in NGF
deprivation–induced death of sympathetic neurons. We
asked whether CsA altered cell death in the presence or ab-
sence of a caspase inhibitor. From this study, we have three
main conclusions. First, CsA blocks Commitment 2, the
commitment-to-die in the presence of a caspase inhibitor, in
NGF-deprived rat sympathetic neurons. Second, CsA does
not prevent cytochrome c release or Commitment 1, the
commitment-to-die in the absence of a caspase inhibitor,
and thus does not act at the premitochondrial phase of the
intrinsic pathway in these neurons. Third, the events that
regulate Commitment 2 in mouse and rat sympathetic neu-
rons are remarkably different.
 
CsA inhibits Commitment 2 in rat sympathetic neurons
 
In many models of neuronal cell death, caspase inhibition pre-
vents apoptosis but not the ultimate death of cells, as they
eventually undergo caspase-independent, nonapoptotic cell
death (Miller et al., 1997; Stefanis et al., 1999; Deshmukh et
al., 2000; Oppenheim et al., 2001). The events responsible for
this nonapoptotic cell death are largely unknown. Here, we
report that in NGF-deprived rat sympathetic neurons, the
PTP inhibitor, CsA, provided robust and sustained inhibition
of Commitment 2, suggesting that PTP opening may be a
critical event in this nonapoptotic cell death (Fig. 1 B). CsA
significantly increased the percentage of cells that could be res-
cued by NGF at all time points between 4 and 35 d of NGF
deprivation. The most dramatic effect was after 10 d of NGF
deprivation, when 
 
 
 
90% of neurons treated with BAF plus
CsA were rescued by NGF readdition versus only 45% of cells
treated with BAF alone. The protective effect of CsA on BAF-
saved neurons was long term, as even after 35 d of NGF dep-
rivation, the latest time point examined in these studies,
Figure 6. CsA does not alter Commitment 2 in mouse sympathetic 
neurons. (A) Comparison of time courses of Commitment 1 and 
Commitment 2 in rat and ICR mouse sympathetic neurons on a 
single graph. Data for rat time courses are taken from Figs. 1 B and 2 
A, whereas those for mouse cells have been previously published 
(Deshmukh et al., 2000). The effects of CsA on Commitment 2 in 
sympathetic neurons from ICR (B) and C57BL/6J (C) mice after 72 h 
of NGF deprivation are shown. CsA, at 3 or 10  M, did not 
significantly increase the proportion of cells that were rescued by NGF 
in either strain of mouse. Values represent mean   SD of one experi-
ment (performed in quadruplicate) that was representative of three 
independent experiments performed at slightly different time points. 
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 60% of CsA-treated, BAF-saved cells were able to respond
to trophic factor readdition. These data suggest that PTP
opening is a critical event in the commitment-to-die in the
presence of a caspase inhibitor in rat sympathetic neurons.
CsA is widely used as an inhibitor of PTP opening, but its
additional activities, such as inhibition of calcineurin/NFAT,
JNK, and p38 pathways (Matsuda and Koyasu, 2000). This
raises the possibility that the observed effect of CsA in these
studies is not due to inhibition of PTP opening. However, the
lack of effect of FK-506, which also inhibits these signaling
pathways but does not block PTP opening, argues against
this. In addition, the inability of CsA to block early cell death
events (Fig. 2) argues that CsA is not inhibiting signal trans-
duction events. Interventions that block these signaling path-
ways, such as depolarizing levels of potassium, cyclic AMP
analogues, and inhibition of the JNK pathway, prevent
cytochrome c release, Commitment 1, and the decrease in
protein synthesis rates in NGF-deprived sympathetic neurons
(Rydel and Greene, 1988; Franklin et al., 1995; Harris et al.,
2002), none of which are seen with CsA treatment. Whereas
we cannot rule out the possibility that CsA has unidentified
activities, we favor the conclusion that CsA blocks Commit-
ment 2 by inhibiting PTP opening.
CsA does not affect Commitment 1
Prolonged opening of the PTP mediates cytochrome c release
in some models of cell death (Marchetti et al., 1996). Our
data indicate that cytochrome c release in sympathetic neu-
rons does not require PTP opening, as CsA had little effect on
this process, as measured by the ability of NGF-deprived cells
to be rescued by NGF (Fig. 2 A) and by cytochrome c immu-
nocytochemistry (Fig. 2 B). This is consistent with the finding
that   m, which would be dissipated upon prolonged PTP
opening, remains intact after cytochrome c release in mouse
sympathetic neurons (Deshmukh et al., 2000). In addition,
for opening of the PTP, which connects the cytosol to the mi-
tochondrial matrix, to cause release of cytochrome c, located
in the intermembrane space, to the cytosol, secondary mito-
chondrial swelling and rupture of the OMM must occur. Ul-
trastructural analysis of NGF-deprived, rat sympathetic neu-
rons reveals no such swelling or obvious rupture of the OMM
after 2 d of NGF deprivation, either in the absence (Martin et
al., 1988) or presence of a caspase inhibitor (Martinou et al.,
1999). At this time point, virtually all cells released cyto-
chrome c, but no cells have reached Commitment 2 (Fig. 1
B). Taken together, these findings provide strong evidence
that PTP opening and rupture of the OMM are not required
for the release of cytochrome c from mitochondria of NGF-
deprived sympathetic neurons.
How does PTP opening cause Commitment 2?
If PTP opening causes commitment-to-die, it could do so by
a gain-of-function mechanism. Loss of OMM integrity by
PTP opening might release death-promoting factors that are
normally sequestered in the mitochondria. As Commitment
2, by definition, occurs only in the absence of caspase activ-
ity, such molecules would have to act in a caspase-indepen-
dent manner. Three candidates that warrant further investi-
gation are AIF (Susin et al., 1999; Joza et al., 2001), HtrA2
(Suzuki et al., 2001), and endonuclease G (Li et al., 2001).
Alternatively, PTP opening could cause Commitment 2 by a
loss-of-function mechanism. Mitochondrial disruption result-
ing from PTP opening might interfere with normal mitochon-
drial functions that are required for continued viability of the
cell, such as ATP generation and calcium homeostasis. Inter-
estingly, ATP inhibits PTP opening (Duchen et al., 1993),
whereas elevated extramitochondrial calcium promotes PTP
opening (Hunter and Haworth, 1979). Therefore, initial PTP
opening could trigger a feed-forward cascade in which impair-
ment of ATP production or calcium buffering promotes addi-
tional PTP opening, further compromising mitochondrial
function. Generation of ATP by oxidative phosphorylation
continues after cytochrome c release in actinomycin D–treated
HeLa cells in the presence of the caspase inhibitor ZVAD-fmk,
suggesting that mitochondrial ATP production after cyto-
chrome c release may be important for continued cell viability
(Waterhouse et al., 2001). The degree to which NGF-deprived,
BAF-saved cells rely on oxidative phosphorylation as a source of
ATP is not known. However, BAF-saved sympathetic neurons
are less sensitive to anoxia than NGF-maintained cells, suggest-
ing that oxidative phosphorylation is not required to maintain
viability by morphological criteria (Xue et al., 2001).
What triggers the initial opening of the PTP?
If PTP underlies Commitment 2, what causes its initial
opening? As noted above, mitochondria have a prominent
role in regulating the cellular homeostasis of two known
modulators of PTP opening: adenine nucleotides and cyto-
solic Ca
2 . By disrupting the ability of mitochondria to reg-
ulate these factors, the mitochondrial hit could serve as the
initial trigger for catastrophic PTP opening. For example,
the translocation of BAX to the mitochondria, an event nec-
essary for Commitment 1 (Putcha et al., 2000), could be
such a trigger. Once at the mitochondrion, BAX could mod-
ulate properties of the PTP, as ectopically overexpressed
BAX does so by interacting with voltage-dependent anion
channel (Shimizu et al., 1999, 2000).
Another way in which mitochondria could trigger this ini-
tial event is through increased reactive oxygen species pro-
duction, another positive regulator of PTP opening (Cromp-
ton et al., 1987; Nieminen et al., 1995). One way in which
  m could be maintained after loss of mitochondrial cyto-
chrome c release is by continued electron transport with
autooxidation of complexes I–III and generation of superox-
ide anions (Cai and Jones, 1998). The contributions of these
events to PTP opening and Commitment 2 are a topic of
current investigation.
The mitochondrial origin of all of these potential triggers
for PTP opening strongly implicates the mitochondrial hit
as an important event in the Commitment 2 pathway. Thus,
mitochondria have a central role in the pathways to both ap-
optotic cell death and nonapoptotic cell death that occurs in
the presence of a caspase inhibitor.
Comparison of Commitment 2 in rat and mouse 
sympathetic neurons reveals key species differences
Sympathetic neurons from mice undergo Commitment 1
at a very similar rate as those from rats. However, the time
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tween these species. Previously published time course stud-
ies show that in sympathetic neurons from ICR and
C57BL/6J mice, 50% reach Commitment 2 by 60 h of
NGF deprivation, and by 96 h, nearly all cells become
committed-to-die (Deshmukh et al., 2000). In contrast,
50% of rat cells reach Commitment 2 after 8 d of NGF
deprivation, demonstrating that Commitment 2 in rat and
mouse sympathetic neurons occurs at drastically different
rates (Figs. 1 B and 6 A).
An even more striking species difference is the com-
plete lack of effect of CsA on Commitment 2 in mouse
sympathetic neurons (Fig. 6, B and C). Nontoxic doses of
CsA did not inhibit Commitment 2 in sympathetic neu-
rons from four strains of mice, representing both inbred
and outbred strains. One possible explanation is that CsA
does not inhibit PTP opening in mouse sympathetic neu-
rons because either these cells do not express cyclophilin
D or the murine orthologue does not interact with CsA.
We did not directly examine the expression of cyclophilin
D, the target of CsA inhibition in the PTP complex, in
either rat or mouse sympathetic neurons. However, these
explanations seem unlikely as cyclophilin D is expressed
and can bind CsA in murine hippocampal neurons (Khas-
pekov et al., 1999).
A more likely explanation is that the mechanism by
which mouse sympathetic neurons commit-to-die in the
presence of a caspase inhibitor does not require PTP open-
ing. The event that causes the loss of   m associated with
Commitment 2 in mouse sympathetic neurons may not
have the same consequences in rat sympathetic neurons.
Consistent with an absence of, or resistance to, this event
in rat cells, Commitment 2 in rat sympathetic neurons oc-
curs with a much slower time course than in mouse cells.
Although purely speculative, this could be related to differ-
ences in the intensity of the mitochondrial hit in these spe-
cies or the ability of neurons from different species to gen-
erate sufficient ATP subsequent to the loss of mitochondrial
cytochrome c.
Implications for therapeutic use of caspase inhibitors
Caspase inhibition has a limited ability to decrease cell
death in some animal models of pathological cell death,
including cerebral (Hara et al., 1997a, 1997b) and car-
diac (Yaoita et al., 1998) ischemia. Because caspase inhib-
itor-saved cells have already undergone the mitochondrial
hit, and the upstream events that cause it, they remain
hypofunctional until the death-inducing stimulus is re-
moved and a normal cellular environment is restored
(e.g., reperfusion after an ischemic insult). In the interim,
these cells are vulnerable to secondary caspase-indepen-
dent, nonapoptotic death, which limits the potential for
functional recovery. Our results suggest that inhibition of
both caspases and PTP opening may provide synergistic
protective effects in models of pathological cell death,
even in paradigms where PTP inhibition alone is not ben-
eficial. In addition, our results highlight the existence of
species-specific pathways of cell death, which must be
considered when applying neuroprotective strategies to
both experimental and pathological cell death.
Materials and methods
Materials
Timed-pregnant Sprague Dawley rats and ICR, C57BL/6, ND4 Swiss Web-
ster, and BALB/c mice were obtained from Harlan. Unless otherwise
noted, all reagents were obtained from Sigma-Aldrich.
Cell culture
Primary cultures of sympathetic neurons from superior cervical ganglia of
postnatal day 0–1 animals were prepared as previously described (Desh-
mukh et al., 1996). After 5 d in culture in medium containing 50 ng/ml
NGF (AM50), cells were deprived of NGF by washing three times with
AM0 (AM50 without NGF) before adding AM0 with goat anti-NGF neu-
tralizing antibody. In experiments requiring inhibition of caspase activity,
50  M BAF (Enzyme Systems) was included in the medium at the time of
deprivation. When used, CsA was also added at the time of NGF depriva-
tion, unless otherwise noted. During the period of NGF deprivation, the
medium was replaced every 3–4 d. The same number of cells could be res-
cued after 6 d in BAF or in BAF plus CsA if fresh medium was provided ev-
ery 2 d or if the medium was not changed, suggesting that CsA did not de-
grade and lose effectiveness during this period (unpublished data).
Rescue experiments
NGF-deprived cultures were rescued by washing cultures four times with
AM50 to remove residual anti-NGF before final addition of AM50. After
7 d in AM50, cells were fixed with 4% paraformaldehyde for at least 8 h at
4 C and stained with 0.05% toluidine blue in TBS for at least 6 h. Intensely
stained cells were counted by using an inverted bright-field microscope
without knowledge of treatment group and expressed as a percentage of
the average number of cells in NGF-maintained sister cultures.
For time-course experiments of the removal of CsA (Fig. 6 A), cultures
were deprived of NGF in the presence of BAF plus CsA. To remove CsA,
cultures were washed twice with AM0 and fed with AM0 containing anti-
NGF and BAF. Fresh medium was given to all cultures every 2 d during the
10 d of NGF deprivation. To quantify the magnitude of the effect of early
removal or delayed addition of CsA, the percent effect was calculated as: 
In both paradigms, the minimum possible effect was 43.6%, or the pro-
portion of NGF-deprived, BAF-saved cells that were rescued after 10 d. In
the experiments shown in Fig. 6 A, the maximum possible effect was
89.6%, the proportion of cells treated with BAF plus CsA that could be res-
cued after 10 d of NGF deprivation. In the experiments represented in Fig.
6 B, the maximum possible effect decreased over time because NGF-
deprived, BAF-saved cells became committed-to-die.
Determination of protein synthesis
To determine rates of protein synthesis cells were labeled for 2 h in 500  l
of MEM lacking cysteine and methionine and supplemented with 10  Ci/
ml 
35S-labeled cysteine and methionine (ICN Biomedical). After 2 h, cells
were washed twice with PBS and lysed in lysis buffer (10 mM Tris, 10 mM
EDTA, 0.5% SDS, pH 7.5). Proteins were precipitated by addition ice-cold
tri-chloroacetic acid (TCA) to a final concentration of 8% and incubating
for at least 2 h on ice. TCA-precipitated protein was then retained on a
0.45- m Protran nitrocellulose filter (Schleicher & Schuell), which was
washed twice with 10% TCA and counted in a liquid scintillation counter.
In experiments where protein synthesis was determined after 10 d of
NGF deprivation, cells were incubated in labeling medium for 4 h to in-
crease the sensitivity of the assay. The small nonneuronal contribution to
total protein synthesis was determined by measuring the protein synthesis
rate of cultures that were maintained in AM0 containing anti-NGF from the
time of plating. The mean nonneuronal value was subtracted from the val-
ues of other samples to calculate the rate of neuronal protein synthesis.
Determination of mitochondrial membrane potential
Mitotracker staining and cytochrome c immunocytochemistry were per-
formed as described (Deshmukh et al., 2000). Briefly, cells were labeled
for 1 h with 1  M Mitotracker Orange CM-H2TMRos (Molecular Probes) in
the appropriate medium and washed extensively with PBS before fixing
and processing for cytochrome c immunocytochemistry.
For JC-1 staining, cells were plated in 96-well white plates with clear
bottoms (Costar). Cultures were washed once with PBS with 1 g/L glucose
and labeled with 3  M JC-1 (Molecular Probes) in PBS with glucose for 20
Percentage of cells rescued mimimum possible effect –
maximum possible effect
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min. After washing once in PBS, cells were either photographed with an
inverted microscope or subjected to quantification by using a Titertek Flu-
oroskan II fluorescent plate reader. Excitation/emission filter sets of 544nm/
590nm, corresponding to the J-aggregate form of JC-1, and 485nm/538nm,
measuring its monomeric form. The JC-1 ratio was calculated as 
where EM is the emission of the sample at the given wavelength and EM
NN
is the average emission at that wavelength of cultures plated in AM0 con-
taining anti-NGF. To completely depolarize mitochondria, cells were pre-
incubated in 10  M FCCP for 10 min before loading with the JC-1 solu-
tion, which also contained 10  M FCCP.
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